OssDsign (OSSD.ST) Stock Price

OssDsign AB develops and sells medical technology products, focusing on implantable solutions for bone healing, particularly in skull surgery. Its primary product, Craniomosaic, is an implant for skull defect repair (cranioplasty), while it also develops bioceramic implants for facial bone augmentation. The company uses proprietary bioceramic technologies that integrate with tissues and support bone ingrowth. Customers include neurosurgeons, craniofacial, and maxillofacial surgeons who purchase these products for surgical procedures. The company generates revenue through the development and sales of its medical technology products, specifically Craniomosaic and bioceramic implants for facial bone augmentation. These products are sold to surgeons specializing in skull and facial bone procedures. The firm’s focus on proprietary bioceramic technologies differentiates its offerings in the medical device market, targeting healthcare professionals who require advanced solutions for bone healing challenges. OssDsign AB’s business model centers on selling implantable medical devices developed using its unique bioceramic technologies. The company’s main customers are neurosurgeons, craniofacial surgeons, and maxillofacial surgeons who use Craniomosaic and facial bone augmentation implants during surgical operations. Revenue is derived from the direct sale of these products to medical professionals for clinical applications in bone healing and reconstruction.